Literature DB >> 25604142

Association of VEGF and VEGFR1 polymorphisms with breast cancer risk in North Indians.

Ruhi Kapahi1, Kamlesh Guleria, Vasudha Sambyal, Mridu Manjari, Meena Sudan, Manjit Singh Uppal, Neeti Rajan Singh.   

Abstract

The aim of present study was to evaluate the relationship between vascular endothelial growth factor (VEGF) -2578C/A, -2549I/D, -460T/C and -7C/T and VEGFR1 -710C/T polymorphisms with risk to breast cancer in North Indians. A total of 204 sporadic breast cancer patients and 204 controls were recruited for this case-control study. Significantly increased frequency of II genotype of -2549I/D polymorphism was observed in patients as compared to control individuals (odds ratio (OR) = 2.76, 95 % confidence interval (CI), 1.55-4.92; p = 0.0005). VEGF -2578AA genotype (OR = 2.87; 95 % CI, 1.61-5.10; p = 0.0003) and A allele (OR = 1.65, 95 % CI, 1.25-2.18; p = 0.0004) were found to be associated with increased risk for breast cancer. Individuals carrying CC genotype (OR = 2.23, 95 % CI, 1.25-3.97) and C allele (OR = 1.42, 95 % CI, 1.07-1.87) of VEGF -460T/C polymorphism were at higher risk of breast cancer. There was no significant difference in genotype and allele distribution of VEGF -7C/T and VEGFR1 -710C/T polymorphisms between cases and control individuals (p > 0.05). Linkage disequilibrium analysis showed a strong linkage between VEGF -2549I/D and -2578C/A polymorphisms (Lewontin's [Formula: see text] = 0.99; r (2) = 0.97), -2549I/D and -460T/C ([Formula: see text] = 0.94; r (2) = 0.84), and -2578C/A and -460T/C polymorphisms ([Formula: see text] = 0.93; r (2) = 0.83). In the present study, we concluded that VEGF -2549I/D, -2578C/A and -460T/C polymorphisms are associated with risk to breast cancer in Punjab, North India.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25604142     DOI: 10.1007/s13277-015-3059-1

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  86 in total

1.  Prognostic importance of VEGF-A haplotype combinations in a stage II colon cancer population.

Authors:  Sanne Kjaer-Frifeldt; Rikke Fredslund; Jan Lindebjerg; Torben Froestrup Hansen; Karen-Lise Garm Spindler; Anders Jakobsen
Journal:  Pharmacogenomics       Date:  2012-05       Impact factor: 2.533

2.  No association between polymorphism in the vascular endothelial growth factor gene at position -460 and sporadic prostate cancer in the Turkish population.

Authors:  Ilke H Onen; Ece Konac; Muzaffer Eroglu; Cagri Guneri; Hasan Biri; Abdullah Ekmekci
Journal:  Mol Biol Rep       Date:  2007-01-11       Impact factor: 2.316

3.  Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal.

Authors:  L E Benjamin; E Keshet
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

4.  Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis.

Authors:  Qianren Jin; Kari Hemminki; Kerstin Enquist; Per Lenner; Ewa Grzybowska; Rüdiger Klaes; Roger Henriksson; Bowang Chen; Jolanta Pamula; Wioletta Pekala; Helena Zientek; Jadwiga Rogozinska-Szczepka; Beata Utracka-Hutka; Göran Hallmans; Asta Försti
Journal:  Clin Cancer Res       Date:  2005-05-15       Impact factor: 12.531

5.  Potentially functional polymorphisms of the vascular endothelial growth factor gene and risk of gastric cancer.

Authors:  Qiao Ke; Jie Liang; Li-Na Wang; Zhi-Bin Hu; Guang-Fu Jin; Yan Zhou; Jian-Ming Wang; Yong-Fei Tan; Zhao-Lai Hua; Yao-Chu Xu; Jing Shen; Hong-Bing Shen
Journal:  Mol Carcinog       Date:  2008-08       Impact factor: 4.784

6.  p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma.

Authors:  B Linderholm; B Lindh; B Tavelin; K Grankvist; R Henriksson
Journal:  Int J Cancer       Date:  2000-01-20       Impact factor: 7.396

7.  Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.

Authors:  Christopher G Willett; Yves Boucher; Emmanuelle di Tomaso; Dan G Duda; Lance L Munn; Ricky T Tong; Daniel C Chung; Dushyant V Sahani; Sanjeeva P Kalva; Sergey V Kozin; Mari Mino; Kenneth S Cohen; David T Scadden; Alan C Hartford; Alan J Fischman; Jeffrey W Clark; David P Ryan; Andrew X Zhu; Lawrence S Blaszkowsky; Helen X Chen; Paul C Shellito; Gregory Y Lauwers; Rakesh K Jain
Journal:  Nat Med       Date:  2004-01-25       Impact factor: 53.440

8.  Lack of association between -460 C/T and 936 C/T of the vascular endothelial growth factor and angiopoietin-2 exon 4 G/A polymorphisms and ovarian, cervical, and endometrial cancers.

Authors:  Ece Konac; H Ilke Onen; Jale Metindir; Ebru Alp; Aydan Asyali Biri; Abdullah Ekmekci
Journal:  DNA Cell Biol       Date:  2007-07       Impact factor: 3.311

9.  Vascular endothelial growth factor levels in relation to oxidative damage and antioxidant status in patients with breast cancer.

Authors:  Deepti Pande; Reena Negi; Seema Khanna; Ranjana Khanna; Hari D Khanna
Journal:  J Breast Cancer       Date:  2011-09-29       Impact factor: 3.588

10.  Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort.

Authors:  Eric J Jacobs; Heather Spencer Feigelson; Elizabeth B Bain; Kerri A Brady; Carmen Rodriguez; Victoria L Stevens; Alpa V Patel; Michael J Thun; Eugenia E Calle
Journal:  Breast Cancer Res       Date:  2006-04-13       Impact factor: 6.466

View more
  8 in total

1.  Haplotype-based association of Vascular Endothelial Growth Factor gene polymorphisms with urothelial bladder cancer risk in Tunisian population.

Authors:  Safa Ben Wafi; Amani Kallel; Mohamed Kacem Ben Fradj; Ahmed Sallemi; Sami Ben Rhouma; Meriam Ben Halima; Haifa Sanhaji; Yassine Nouira; Riadh Jemaa; Moncef Feki
Journal:  J Clin Lab Anal       Date:  2018-06-29       Impact factor: 2.352

2.  Impact of VEGFA promoter polymorphisms on esophageal cancer risk in North-West Indians: a case-control study.

Authors:  Kamlesh Guleria; Simranjot Kaur; Deepanshi Mahajan; Vasudha Sambyal; Meena Sudan; Manjit Singh Uppal
Journal:  Genes Genomics       Date:  2022-06-29       Impact factor: 2.164

3.  Association of VEGF haplotypes with breast cancer risk in North-West Indians.

Authors:  Vasudha Sambyal; Kamlesh Guleria; Ruhi Kapahi; Mridu Manjari; Meena Sudan; Manjit Singh Uppal; Neeti Rajan Singh
Journal:  BMC Med Genomics       Date:  2021-08-24       Impact factor: 3.063

4.  Association Between Vascular Endothelial Growth Factor Gene Polymorphisms with Breast Cancer Risk in an Iranian Population.

Authors:  Maryam Rezaei; Mohammad Hashemi; Sara Sanaei; Mohammad Ali Mashhadi; Mohsen Taheri
Journal:  Breast Cancer (Auckl)       Date:  2016-07-04

5.  Role of VEGFA gene polymorphisms in colorectal cancer patients who treated with bevacizumab.

Authors:  Wei Cui; Feng Li; Qiang Yuan; Gang Chen; Cailing Chen; Bo Yu
Journal:  Oncotarget       Date:  2017-11-06

6.  Influence of polymorphisms in the vascular endothelial growth factor gene on allograft rejection after kidney transplantation: a meta-analysis.

Authors:  Thanee Eiamsitrakoon; Phuntila Tharabenjasin; Noel Pabalan; Hamdi Jarjanazi; Adis Tasanarong
Journal:  F1000Res       Date:  2021-02-10

Review 7.  Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges.

Authors:  Ramesh Butti; Sumit Das; Vinoth Prasanna Gunasekaran; Amit Singh Yadav; Dhiraj Kumar; Gopal C Kundu
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401

8.  Potential Impact of Vascular Endothelial Growth Factor Gene Variation (-2578C>A) on Breast Cancer Susceptibility in Saudi Arabia: a Case-Control Study

Authors:  Ibrahim Abdullah Al Balawi; Rashid Mir; F M Abu-Duhier
Journal:  Asian Pac J Cancer Prev       Date:  2018-04-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.